Caredx Market Capitalization from 2010 to 2024

CDNA Stock  USD 23.34  0.31  1.31%   
Caredx's Market Cap is increasing over the years with slightly volatile fluctuation. Overall, Market Cap is expected to go to about 686.5 M this year.
Check Caredx financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Caredx's main balance sheet or income statement drivers, such as Depreciation And Amortization of 20.8 M, Interest Expense of 3.7 M or Selling General Administrative of 123.8 M, as well as many indicators such as Price To Sales Ratio of 4.25, Dividend Yield of 0.0 or PTB Ratio of 2.59. Caredx financial statements analysis is a perfect complement when working with Caredx Valuation or Volatility modules.
  
Check out the analysis of Caredx Correlation against competitors.

Latest Caredx's Market Capitalization Growth Pattern

Below is the plot of the Market Cap of Caredx Inc over the last few years. It is Caredx's Market Cap historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Caredx's overall financial position and show how it may be relating to other accounts over time.
ViewLast Reported 1.27 B10 Years Trend
Slightly volatile
   Market Cap   
       Timeline  

Caredx Market Capitalization Regression Statistics

Arithmetic Mean668,330,384
Geometric Mean255,456,786
Coefficient Of Variation144.83
Mean Deviation652,479,060
Median171,068,330
Standard Deviation967,951,193
Sample Variance936929.5T
Range3.3B
R-Value0.52
Mean Square Error735305.1T
R-Squared0.27
Significance0.05
Slope112,726,711
Total Sum of Squares13117013.2T

Caredx Market Capitalization History

2024686.5 M
2023547.6 M
2022608.4 M
20212.4 B
20203.4 B
2019909.2 M
2018896 M

About Caredx Financial Statements

Caredx stakeholders use historical fundamental indicators, such as Caredx's Market Capitalization, to determine how well the company is positioned to perform in the future. Although Caredx investors may analyze each financial statement separately, they are all interrelated. For example, changes in Caredx's assets and liabilities are reflected in the revenues and expenses on Caredx's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Caredx Inc. Please read more on our technical analysis and fundamental analysis pages.
CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. The company was incorporated in 1998 and is headquartered in South San Francisco, California. CareDx operates under Diagnostics Research classification in the United States and is traded on NASDAQ Exchange. It employs 633 people.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Caredx Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Caredx's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Caredx Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Caredx Inc Stock:
Check out the analysis of Caredx Correlation against competitors.
You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Caredx. If investors know Caredx will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Caredx listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(2.69)
Revenue Per Share
5.952
Quarterly Revenue Growth
0.234
Return On Assets
(0.07)
Return On Equity
(0.43)
The market value of Caredx Inc is measured differently than its book value, which is the value of Caredx that is recorded on the company's balance sheet. Investors also form their own opinion of Caredx's value that differs from its market value or its book value, called intrinsic value, which is Caredx's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Caredx's market value can be influenced by many factors that don't directly affect Caredx's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Caredx's value and its price as these two are different measures arrived at by different means. Investors typically determine if Caredx is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Caredx's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.